Image

2019 Cannabis Business Award's

Publication of the Year

WEDNESDAY, SEPTEMBER 17, 2025

 

FMCPG HAS BEEN SERVING

AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY

SINCE 2020

 

 

FMCPG MEETING

LINK BELOW 

REGISTER FOR THE NEXT MEETING OF THE FMCPG
WEDNESDAY

OCTOBER 1, 2025

THE

"FLORIDA MEDICAL CANNABIS

PHYSICIAN GROUP"

(FMCPG)

FOR ALL

"MEDICAL MARIJUANA DOCTORS"

AND "MMTC DIRECTORS ONLY "

 

DISCUSS AND UPDATE THE LEGISLATIVE PRIORITIES FOR

2025/2026

 

REVIEW OF THE OMMU AND  CHANGES TO THE DOCTOR'S AND PATIENT INPUT PORTALS ON THE OMMU WEBSITE. 

DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES

 

REF'S ISSUES AND SOLUTIONS

 

TIME TO RENEW YOUR MEMBER IN FMCPG

CLICK HERE FOR THE MEMBERSHIP FORM

 

USE THIS LINK TO REGISTER FOR THE NEXT MEETING  - WEDNESDAY, OCTOBER 1, 2025

 

CLICK HERE ON LINK BELOW

JOIN THE NEXT MEETING
OF THE FMCPG

WEDNESDAY

OCTOBER 1, 2025
 
 

 MEDICAL CANNABIS PHYSICIAN

PROMOTION PACKAGE BY

CANNABIS NEWS FLORIDA 

 

ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).

 

E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.

 

The cost of this program is ONLY $500

AND INCLUDES A ONE YEAR MEMBERSHIP IN THE FMCPG

 

**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.

 

IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785

 
 

NEWS FROM THE PAST WEEK

RELATING TO THE BUSINESS OF

MMTC'S

IN FLORIDA

 

Click on Company Logo to be Transferred to Web Site

Trulieve Launches Five New Onward and Upward Flavor

New “Stronger Sips” collection includes Berry Smash, Cosmopolitan, Lemon Drop Martini, Paloma and Half & Half

Sept. 12, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the launch of five new 10 milligram flavors of Onward and Upward THC-infused beverages.

“Strong sell through of our 10 milligram flavors highlights the growing demand for THC beverages,” said Trulieve Chief Executive Officer Kim Rivers. “We are pleased to launch these new flavors, providing consumers greater choice within our Onward cocktail alternative and Upward infused energy drink assortments.”

New flavors include Onward Berry Smash, Cosmopolitan, Lemon Drop Martini and Paloma, and Upward Half & Half iced tea & lemonade. These bold flavors are crafted in the USA and infused with naturally derived THC and CBD.

READ MORE

 

Trulieve Rewards

 

Trulieve Rewards is a customer rewards program offering patients and customers in participating states an easy platform to earn points on every purchase at Trulieve dispensaries. We've revamped and refreshed our old cannabis loyalty program to reward cannabis enthusiasts loyal to Trulieve with savings, perks, and points every time they shop for cannabis products

 

JOIN NOW

 
 

CLICK HERE FOR MORE INFORMATION ABOUT THE SUNBURN CANNABIS PROMOTIONS

 
 
 
 
 
 
 

Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership

CHICAGO–September 16, 2025 – Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside in Proctorville, Ohio. It is the Company’s sixth dispensary in Ohio and 71st nationwide.

Cresco Labs opened a new Sunnyside dispensary at 200 State Street in Proctorville, Ohio.Cresco Labs opened a new Sunnyside dispensary at 200 State Street in Proctorville, Ohio.
“We’re thrilled to bring the Sunnyside experience to Proctorville, the first of three new dispensaries we’re opening in Ohio over the next several months,” said Charlie Bachtell, CEO of Cresco Labs. “This new location is a great opportunity for organic growth in a market where we are number one in retail market share and number three in branded product share.”

“Proctorville is proud to welcome Sunnyside to our community,” said Proctorville Mayor Bill Elliott. “We’ve already seen the benefits of new job creation, and we’re eager to put the additional revenue to work improving our streets, strengthening public safety, and enhancing our parks.”

READ MORE

 
 
 

Verano Broadens Florida Retail Footprint to 82 Dispensaries with the Opening of MÜV Crystal River

MÜV Crystal River is located at 941 NE US Hwy 19, a busy thoroughfare with an average daily traffic count of 23,000 vehicles1
The dispensary is Verano’s first MÜV location in Florida’s Citrus County, a growing region with over 150,000 residents2
Verano’s active operations span 13 states, comprised of 158 dispensaries and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity
CHICAGO, Sept. 16, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Crystal River on September 19, elevating the Company’s Florida retail footprint to 82 MÜV locations and 158 dispensaries nationwide. Located at 941 NE US Hwy 19, MÜV Crystal River, will be open from Monday to Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m. local time.

Situated in Florida’s Citrus County, a growing region with over 150,000 residents2, MÜV Crystal River is the first MÜV dispensary in the the county. Located a few blocks from Kings Bay Riverwalk, MÜV Crystal River is conveniently surrounded by local businesses and attractions including restaurants, hotels and scenic wildlife. The opening of MÜV Crystal River also expands the Company’s retail footprint in western Florida near existing MÜV dispensaries in Ocala, Spring Hill and Port Richey.

“We are excited to welcome patients at MÜV Crystal River, our first dispensary in Citrus County, and offering our expansive suite of award-winning products in a friendly, hospitality-driven dispensary environment,” said John Tipton, President of the Southern Region. “We’re grateful for the opportunity to serve the medical cannabis community in western Florida as we expand our footprint in the region, and we look forward to welcoming patients at MÜV Crystal River for years to come.”

Most recently, the Company introduced a series of new products in Florida in fast-growing categories, including Savvy 10-pack barrel-style pre-rolls, incorporating a unique yet recognizable barrel-style shape, delivering consumer affordability without sacrificing quality, and Avexia’s award-winning topicals, including pain relief balm, lotion and bath soak designed for localized, fast-acting relief and carefully formulated with a blend of high-quality cannabinoids and essential oils.

READ MORE

Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada

Sept. 15, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the Company’s Board of Directors approved, and the Company will be seeking shareholder approval of, a proposed plan to redomicile Verano Holdings Corp. from British Columbia, Canada, to the State of Nevada.

Verano believes that redomiciling in the United States better aligns with its U.S. based business and operations and streamlines its organizational and regulatory structure within the United States, among other reasons discussed in the preliminary proxy statement filed by the Company on September 12, 2025 with the U.S. Securities and Exchange Commission and in Canada on SEDAR+ (the “Preliminary Proxy Statement”).

“Since inception and our 2021 go-public transaction, we’ve focused on ways to unlock shareholder value and create potential catalysts for the business, including enhancements to our corporate structure and executing a capital markets strategy that positions Verano to capitalize on near and long-term growth opportunities,” said George Archos, Verano Chairman and Chief Executive Officer. “From our 2023 strategic decision to list Company shares on Cboe Canada, a senior U.S.-based exchange with global operations, to our redomiciling in the U.S. as a newly-registered Nevada enterprise, we are prepared to leverage opportunities that benefit the Company and our shareholders.”

READ MORE

 
 

iAnthus Expands Florida Footprint with GrowHealthy Dispensary Opening in Tamarac

New Location Marks 23rd Growhealthy Storefront, Bringing Premium Medical

Products and Engaging Retail Experience to Broward County

NEW YORK and TORONTO, Sept. 11, 2025  — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, today has announced the opening of its 23rd GrowHealthy dispensary in Florida, now welcoming patients in Tamarac. The dispensary opens today with access to new, premium in-house brands: Sunshine State & The Vault.

“We’re proud to bring GrowHealthy to Tamarac and become part of this vibrant community,” said Richie Proud, CEO of iAnthus. “Every new opening is about more than a dispensary; it’s about expanding access for patients and supporting wellness of patients. This location was designed to reflect the spirit of Tamarac, while delivering the same high standards of quality that patients across Florida expect from GrowHealthy.”

GrowHealthy distinguishes itself in Florida through a focus on premium genetics and whole-plant wellness. Built on the foundation of cultivators and caregivers, the company leads with a flower-first philosophy, strong community ties, and a deep respect for the cannabis plant. The Tamarac locations debuts GrowHealthy’s refreshed store design, blending Florida’s vibrant aesthetic while paying tribute to Tamarac with a mural unique to the city. The dispensary offers patients a wide range of options, including flower, vapes, concentrates, and additional products curated to meet the diverse wellness needs of Florida patients.

READ MORE

 
 
 
 
 
 
 

FINO BRANDS, INC

 
 
 
 
 

PROSPERITY MEDICAL, LLC

 

THERATRUE FLORIDA

 
 

Cannabis companies are recognizing the theme of ROIC maximization, investing in going deep in state markets where they can be a significant factor and obtain economies of scale while scaling back or eliminating territories where they can’t. Companies that successfully execute this strategy will be rewarded by superior valuation multiples or become attractive takeout candidates.

This week's Viridian Chart of the Week presents two different views of the ROIC issue that may restrain new capital investment into the cannabis industry: even if rescheduling occurs, the cannabis industry’s return on invested capital is too low to justify the amount of capital it currently employs.

Finance theory teaches us that if Return on Invested Capital (ROIC is less than Weighted Average Cost of Capital (WACC), that company (or industry) is destroying value rather than creating it.
Investors would be better off if the firm or industry returned capital by stock repurchases or dividends.

Return on Invested Capital is defined as After-Tax Operating Income divided by Invested Capital. This ratio can be decomposed into two more fundamental measures: Revenues / Invested Capital x After Tax Operating Income / Revenues = ROIC.

Revenues / Invested Capital can be thought of as a measure of capital intensity; a company with a lower Revenues / Invested Capital requires more additional capital to add $1 of incremental revenue. The second ratio, After Tax Operating Income / Revenues ( measured on the horizontal axis), is a measure of after-tax profitability. In calculating these ratios, we have consistently used a marginal tax rate of 25%. Accordingly, our figures already give cannabis companies credit for the elimination of 280E. In each case, we used consensus estimates of 2026 revenues and EBITDA and information from June 2025 balance sheets to calculate invested capital (book equity plus debt-cash).

There are essentially two ways to increase ROIC: become more profitable or become less capital-intensive.

The graph above examines the components of ROIC for cannabis relative to other industries that are frequently compared to cannabis or considered potential acquirers of cannabis companies. All non-cannabis industries are displayed with blue circles, while three sectors of cannabis (Large Canadian LPs, Tier 1 US MSOs, and Tier 2 US MSOs) are shown by green circles. The red line shows the hypothetical combinations of factors that would create an ROIC of 10%—moving in the direction of up or to the right increases ROIC. Of the fourteen industry sectors (including cannabis) on the graph, 10 of them are above the 10% ROIC line. The three cannabis sectors have the lowest ROICs on the chart, both due to low profitability and low capital productivity.

What will it take to improve the ROIC of cannabis? Consolidation of the industry may result in more oligopolistic pricing and allow for higher operating margins; however, this is a long-term impact that will take years to occur. Similarly, better asset efficiency is likely to happen through full legalization, as firms would then be able to centralize production and distribution. A shorter-term partial fix might be found through the ongoing process of divesting less profitable/productive markets. We have seen an increase in that activity over the last twelve months, including Trulieve leaving Massachusetts, Curaleaf abandoning most of the Western States, and the current restructuring of AYR, which will result in a reduction of core markets.

The second graph above breaks out the components of ROIC for each of the eleven companies we used in our cannabis Tier 1 and Tier 2 aggregates. Note that only four companies, including Jushi, TerrAscend, Trulieve, and Glass House, are at or above the 10% ROIC frontier, which we believe is a reasonable estimate of minimum WACC for the industry. Jushi has mid-range profitability but excels in producing the highest revenue-to-invested-capital ratio of the group. In contrast, Glass House has strong projected operating margins with median revenue to invested capital

For More Analysis View This Week's Viridian Chart of the Week

 

About Viridian Capital Advisors

Since launching in 2014, Viridian Capital Advisors has become one of the most respected and experienced advisory and M&A firms specializing in the cannabis industry. We provide a wide range of services, including:

Strategic Advisory Consulting: Including valuation, financial modeling, restructuring and fairness opinions.

Mergers & Acquisitions:  Transaction advisory and execution.

Capital Raises: Including debt and equity.

 

Many of our assignments begin with a basic question: "What should I do now?"  

Raise capital to expand? What kind of capital is most appropriate? 
 

Acquire another company? What are the advantages and pitfalls? 

Sell my company?  What valuations can i achieve?  What transaction structures are possible?


Put our experience, data and depth of senior talent behind your next transaction.

Contact

Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com

Frank Colombo
Managing Director
Viridian Capital Advisors, LLC
914.523.4730
fcolombo@viridianca.com

 
 

NATIONAL AND INTERNATIONAL NEWS

 

HSS Pilot Study Announced at ESRA Annual Meeting Examines the Role of Cannabidiol in Total Knee Arthroplasty Pain Management

SEPTEMBER 11, 2025 – Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, presented a research study at the European Society of Regional Anesthesia and Pain Therapy (ESRA) Annual Meeting, highlighting the effects of cannabidiol in patients undergoing bilateral total knee arthroplasty, often referred to as double knee replacement. Cannabidiol (CBD), a non-intoxicating phytocannabinoid, has shown limited clinical evidence of its pain-relieving and opioid-sparing properties. Currently, the only FDA approved cannabidiol solution is available by prescription for specific conditions.

The study demonstrated the importance of monitoring accurate dosage and highlighted the need for additional long-term studies to better understand the role of cannabidiol in post-surgery pain management.

The pilot study, conducted over four years, followed 36 patients who received cannabidiol as a part of their treatment following surgery. Previous surveys at HSS and other institutions have shown that many patients are using cannabidiol to self-medicate, creating challenges for providers. To ensure safety, only relatively healthy patients were enrolled due to the demanding and invasive nature of the surgery.

“These patients experience significant pain after surgery and often require high doses of opioids,” said Alexandra Sideris, PhD, Director of the Pain Prevention Research Center at HSS and one of the co-authors of the study. “We approached this study knowing that if we were going to study a cannabis constituent to try to see if there is any benefit, we need to start with a population that could significantly benefit from adding on an additional medication. It is very painful to have both knees replaced.”

READ MORE

 
 

BELOW ARE THE  LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND

DISPENSARIES IN THE STATE OF FLORIDA

Link to current Qualified Medical Marijuana Physicians in Florida>

Listing of MMTC dispensing facilities>

 

SUMMARY OF THE MEDICAL CANNABIS PROGRAM IN FLORIDA ANNUAL REPORT JULY 2022- JUNE 2023

 

CLICK ON IMAGE BELOW FOR A PDF COPY

 

 QUALIFIED PATIENTS

OVER 924,000

AND

733

DISPENSING LOCATIONS

Image

LATEST OMMU REPORTS FROM OFFICE OF MEDICAL  MARIJUANA USE IN THE STATE OF FLORIDA

Highlights from 
SEPTEMBER 12, 2025

Report 

BY THE NUMBERS

Qualified Patients: (Active ID Card)

SEPT     12  2025            924,473

SEPT     05  2025            923,918

AUG      29  2025             923,629

AUG      22  2025             923,228

AUG      15  2025             922,769

 AUG     08  2025             921,698

 

 

Patients Last Week: 555

Qualified Ordering Physicians: 2,423

New Doctors Last Week:  0

 

Reporting Period:  SEPT 5   -  SEPT 11, 2025 

Amount of Medical Marijuana Dispensed -  (mgs THC) 374,887,301

Amount of Low-THC Cannabis Dispensed -  (mgs CBD)  0

Amount of Marijuana in a From for Smoking (oz) 132,397.698

Approved Dispensing Locations: 733

ADDED LAST WEEK - 3

GROWHEALTHY - TAMARAC

PLANET 13 - PACE

CURALEAF- APOPKA

CLICK HERE FOR CURRENT OMMU REPORT
Alternate text
 

UPCOMING MEETING AND CONFERENCES

 
 

ADVERTISEMENT OPPORTUNITIES

 

If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.

 

Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:

· MMTC PROMOS LISTED IN EACH E-NEWSLETTER 
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters


For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com

 

Click Here to Unsubscribe

 

CANNABIS NEWS FLORIDA

{YOURCOMPANY.ADDRESS}

{COPYRIGHT.YEAR}